Safety syringe heads to market

A ready-to-fill syringe having integrated passive safety features within the glass barrel is heading to market. The Unifill syringe (pre-commercially known as the Unilife Ready-to-Fill Syringe) is designed for compatibility with most of the drug filling and packaging systems of its maker's pharmaceutical customers. It lets operators control the rate of passive needle retraction directly from the body into the barrel of the syringe to protect those at risk of needlestick injury.

The syringe is being commercialized by Unilife and a pharmaceutical partner. Unilife says in an announcement that it is working on additional products that will carry the Unifill brand for marketing to drug makers.

Unilife currently markets Unitract brand 1-milliliter safety syringes for the administration of vial- or ampule-packaged medications at healthcare facilities and by patients. The company says that two billion prefilled syringes are used globally each year, and drug makers are migrating to products that comply with needlestick prevention laws.

- here's the announcement


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.